Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3936)
All Articles published online
|
Publishing Process of This Article
|
Jul 16, 2021 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Costanzo G, Cordeddu W, Chessa L, Del Giacco S, Firinu D. COVID-19: Considerations about immune suppression and biologicals at the time of SARS-CoV-2 pandemic. World J Clin Cases 2021; 9(20): 5352-5357 [PMID: 34307589 DOI: 10.12998/wjcc.v9.i20.5352] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i20/5352.htm |
| Number | Citing Articles |
| 1 |
Haitham M.H. Qutob, Ramadan A. Saad, Hamza Bali, Abdulaziz Osailan, Jumana Jaber, Emad Alzahrani, Jamilah Alyami, Hani Elsayed, Raed Alserihi, Osama A. Shaikhomar. Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease. Medicina Clínica 2022; 159(12): 569 doi: 10.1016/j.medcli.2022.02.013
|
| 2 |
Drew Provan, Adrian C Newland. Investigational drugs for immune thrombocytopenia. Expert Opinion on Investigational Drugs 2022; 31(7): 715 doi: 10.1080/13543784.2022.2075340
|
| 3 |
Haitham M.H. Qutob, Ramadan A. Saad, Hamza Bali, Abdulaziz Osailan, Jumana Jaber, Emad Alzahrani, Jamilah Alyami, Hani Elsayed, Raed Alserihi, Osama A. Shaikhomar. Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease. Medicina Clínica (English Edition) 2022; 159(12): 569 doi: 10.1016/j.medcle.2022.02.029
|